US Patent Issued to Novartis on June 24 for "Regimens and methods of treating multiple sclerosis using ofatumumab" (Swiss, American Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,290, issued on June 24, was assigned to Novartis AG (Basel, Switzerland).

"Regimens and methods of treating multiple sclerosis using ofatumumab" was invented by Erik Wallstrom (Basel, Switzerland), Marina Savelieva Praz (Binningen, Switzerland), Algirdas Jonas Kakarieka Weisskopf (Basel, Switzerland) and Joseph Michael Kahn (Belle Mead, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to treatment regimens for treating Multiple Sclerosis (MS). These methods utilize administration of ofatumumab, an anti-CD20 monoclonal antibody, to the patient during a loading dose regimen and a maintenance regimen."

The patent was file...